Pfizer Animal Health begins reorganisation ahead of possible sale

Pfizer Animal Health is to undergo changes to its corporate structure as parent company Pfizer continues to consider the potential sale of the business.

The pharmaceutical firm's Indian subsidiary is to see its animal health operations incorporated into the larger veterinary medicines division, a move that would allow potential buyers to assess the business as a whole more easily.

Joan Campion, a Pfizer spokeswoman, told Bloomberg, said: "In order for any potential transaction with animal health, in some countries the business needs to be separated out from the legal entity that's there."

Pfizer is yet to confirm whether the business unit will be sold, spun off or divested, though any potential transaction is due to take place over the next year.

A strategic review for Pfizer Animal Health has been ongoing since July 2011, as Pfizer is seeking to focus more on its core biopharmaceutical sector operations.

Pfizer Animal Health is one of the largest companies of its kind in the world, operating in more than 60 nations.